Black men have a higher risk of developing prostate cancer, but they are often excluded from clinical trials for the disease, new research claims.
Researchers found many African American men are shut out of these experiments because they have slightly low levels of neutrophils, a common type of white blood cell important to fighting off infections. Exclusion from these clinical trials – which give participants access to the latest medical treatments – could prevent black men from receiving proper treatment. The findings, published in JAMA Oncology, suggest researchers designing clinical trials set entry criteria that makes it harder for black patients to participate. Read more